A cell therapy, referred to as agenT-797, is being explored for its potential in treating solid tumors. The therapy, which involves iNKT cells, may also have applications in other areas, including gastrointestinal cancers and severe respiratory conditions. Reports suggest that the therapy has shown promise, with one outlet indicating a significant breakthrough in testicular cancer treatment, although its overall efficacy and approval status are unclear.